hepatic cell therapy (LCT)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehepatic cell therapy (LCT)
Drug Alias NameFac8Cell
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLiving Cell Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLiving Cell Technologies
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A